Modeling breast cancer progression in 4-D

Breast Cancer Metastasis and Drug Resistance: Progress and Prospects

Volumn , Issue , 2012, Pages 177-188

  Sameni, Mansoureh ^a   Mullins, Stefanie R ^a   Moin, Kamiar ^a   Sloane, Bonnie F ^a   Osuala, Kingsley ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acidosis; Breast cancer; Extracellular matrix; Four dimensional (4D) cell modeling; Hypoxia; In vitro models; Live cell imaging; Malignant progression; Mammary architecture and microenvironment engineering (MAME); Modeling breast cancer; Three dimensional (3D) cell culture; Tumor microenvironment

Indexed keywords

EID: 84929535502     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-5647-6_10     Document Type: Chapter

References (82)

1. Carrel A, Burrows MT (1911) An addition to the technique of the cultivation of tissues in vitro. J Exp Med 14(3): 244-247
2. Carrel A, Burrows MT (1911) Cultivation in vitro of malignant tumors. J Exp Med 13(5): 571-575
3. Evans MJ, Kaufman MH (1981) Establishment in culture of pluripotential cells from mouse embryos. Nature 292(5819): 154-156
4. Huynh T, Abraham G et al (1999) Remodeling of an acellular collagen graft into a physiologically responsive neovessel. Nat Biotechnol 17(11): 1083-1086
5. Rustad KC, Sorkin M et al (2010) Strategies for organ level tissue engineering. Organogenesis 6(3): 151-157
6. Perdue ML, Arnold F et al (2011) The future of cell culture-based influenza vaccine production. Expert Rev Vaccines 10(8): 1183-1194
7. Mantovani A (1994) Tumor-associated macrophages in neoplastic progression: a paradigm for the in vivo function of chemokines. Lab Invest 71(1): 5-16
8. Brigati C, Noonan DM et al (2002) Tumors and inflammatory infiltrates: friends or foes? Clin Exp Metastasis 19(3): 247-258
9. Friedl P, Alexander S (2011) Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 147(5): 992-1009
10. Raghunand N, Martinez-Zaguilan R et al (1999) pH and drug resistance II turnover of acidic vesicles and resistance to weakly basic chemotherapeutic drugs. Biochem Pharmacol 57(9): 1047-1058
11. Gillies RJ, Gatenby RA (2007) Hypoxia and adaptive landscapes in the evolution of carcinogenesis. Cancer Metastasis Rev 26(2): 311-317
12. Höckel M, Vaupel P (2001) Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 93(4): 266-276
13. Gatenby RA, Gawlinski ET (1996) A reaction-diffusion model of cancer invasion. Cancer Res 56(24): 5745-5753
14. Crowther M, Brown NJ et al (2001) Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors. J Leukoc Biol 70(4): 478-490
15. Sauvant C, Nowak M et al (2008) Acidosis induces multi-drug resistance in rat prostate cancer cells (AT1) in vitro and in vivo by increasing the activity of the p-glycoprotein via activation of p38. Int J Cancer 123(11): 2532-2542
16. Streuli CH, Bailey N et al (1991) Control of mammary epithelial differentiation: basement membrane induces tissue-specific gene expression in the absence of cell-cell interaction and morphological polarity. J Cell Biol 115(5): 1383-1395
17. Kenny PA, Lee GY et al (2007) The morphologies of breast cancer cell lines in threedimensional assays correlate with their profiles of gene expression. Mol Oncol 1(1): 84-96
18. Harma V, Virtanen J et al (2010) A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses. PLoS ONE 5(5): e10431
19. Simian M, Hirai Y et al (2001) The interplay of matrix metalloproteinases, morphogens and growth factors is necessary for branching of mammary epithelial cells. Development 128(16): 3117-3131
20. Debnath J, Muthuswamy SK et al (2003) Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 30(3): 256-268
21. Debnath J, Brugge JS (2005) Modelling glandular epithelial cancers in three-dimensional cultures. Nat Rev Cancer 5(9): 675-688
22. Krause S, Maffini MV et al (2010) The microenvironment determines the breast cancer cells' phenotype: organization of MCF7 cells in 3D cultures. BMC Cancer 10: 263
23. Gudjonsson T, Ronnov-Jessen L et al (2002) Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition. J Cell Sci 115(Pt 1): 39-50
24. Sternlicht MD, Kedeshian P et al (1997) The human myoepithelial cell is a natural tumor suppressor. Clin Cancer Res 3(11): 1949-1958
25. Lee SW, Reimer CL et al (1998) Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells. Oncogene 16(11): 1391-1397
26. Bissell MJ, Radisky D (2001) Putting tumours in context. Nat Rev Cancer 1(1): 46-54
27. Runswick SK, O'Hare MJ et al (2001) Desmosomal adhesion regulates epithelial morphogenesis and cell positioning. Nat Cell Biol 3(9): 823-830
28. Leek RD, Hunt NC et al (2000) Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer. J Pathol 190(4): 430-436
29. Lewis JS, Landers RJ et al (2000) Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas. J Pathol 192(2): 150-158
30. Gooden MJ, de Bock GH et al (2011) The prognostic influence of tumour-infiltrating lymphocytes in cancer: A systematic review with meta-analysis. Br J Cancer 105(1): 93-103
31. Bell D, Chomarat P et al (1999) In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. J Exp Med 190(10): 1417-1426
32. Treilleux I, Blay JY et al (2004) Dendritic cell infiltration and prognosis of early stage breast cancer. Clin Cancer Res 10(22): 7466-7474
33. DeNardo DG, Coussens LM (2007) Inflammation and breast cancer balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression. Breast Cancer Res 9(4): 212
34. Wang X, Song G et al (2010) Fabrication and characterization of nano-composite scaffold of PLLA/silane modified hydroxyapatite. Med Eng Phys 32(4): 391-397
35. Barker TH (2011) The role of ECM proteins and protein fragments in guiding cell behavior in regenerative medicine. Biomaterials 32(18): 4211-4214
36. Chen G, Sato T et al (2004) Tissue engineering of cartilage using a hybrid scaffold of synthetic polymer and collagen. Tissue Eng 10(3-4): 323-330
37. Mandal BB, Kundu SC (2009) Cell proliferation and migration in silk fibroin 3D scaffolds. Biomaterials 30(15): 2956-2965
38. Dutta RC, Dutta AK (2010) Comprehension of ECM-cell dynamics: a prerequisite for tissue regeneration. Biotechnol Adv 28(6): 764-769
39. Curtis A, Wilkinson C (1997) Topographical control of cells. Biomaterials 18(24): 1573-1583
40. Kirkpatrick CJ, Krump-Konvalinkova V et al (2002) Tissue response and biomaterial integration: the efficacy of in vitro methods. Biomol Eng 19(2-6): 211-217
41. Brammer KS, Frandsen CJ et al (2012) TiO(2) nanotubes for bone regeneration. Trends Biotechnol
42. Kubota Y, Kleinman HK et al (1988) Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. J Cell Biol 107(4): 1589-1598
43. Lin CQ, Bissell MJ (1993) Multi-faceted regulation of cell differentiation by extracellular matrix. FASEB J 7(9): 737-743
44. WebberMM, BelloDet al (1997) Acinar differentiation by non-malignant immortalized human prostatic epithelial cells and its loss by malignant cells. Carcinogenesis 18(6): 1225-1231
45. Bissell MJ, Radisky DC et al (2002) The organizing principle: microenvironmental influences in the normal and malignant breast. Differentiation 70(9-10): 537-546
46. Wang AZ, Ojakian GK et al (1990) Steps in the morphogenesis of a polarized epithelium II disassembly and assembly of plasma membrane domains during reversal of epithelial cell polarity in multicellular epithelial (MDCK) cysts. J Cell Sci 95(1): 153-165
47. Bello-DeOcampo D, Kleinman HK et al (2001) Laminin-1 and alpha6beta1 integrin regulate acinar morphogenesis of normal and malignant human prostate epithelial cells. Prostate 46(2): 142-153
48. Berking C, Herlyn M (2001) Human skin reconstruct models: a new application for studies of melanocyte and melanoma biology. Histol Histopathol 16(2): 669-674
49. O'Brien LE, Zegers MM et al (2002) Opinion: building epithelial architecture: insights from three-dimensional culture models. Nat Rev Mol Cell Biol 3(7): 531-537
50. Zeilinger K, Sauer IM et al (2002) Three-dimensional co-culture of primary human liver cells in bioreactors for in vitro drug studies: effects of the initial cell quality on the long-term maintenance of hepatocyte-specific functions. Altern Lab Anim 30(5): 525-538
51. Krause S, Maffini MV et al (2008) A novel 3D in vitro culture model to study stromal-epithelial interactions in the mammary gland. Tissue Eng Part C Methods 14(3): 261-271
52. Imbalzano KM, Tatarkova I et al (2009) Increasingly transformed MCF-10A cells have a progressively tumor-like phenotype in three-dimensional basement membrane culture. Cancer Cell Int 9: 7
53. Sabeh F, Shimizu-Hirota R et al (2009) Protease-dependent versus -independent cancer cell invasion programs: three-dimensional amoeboid movement revisited. J Cell Biol 185(1): 11-19
54. Rosines E, Johkura K et al (2010) Constructing kidney-like tissues from cells based on programs for organ development: toward a method of in vitro tissue engineering of the kidney. Tissue Eng Part A 16(8): 2441-2455
55. Polizzotti LM, Oztan B, Bjornsson C, Shubert K, Yener B, Plopper G (2012) Novel image analysis approach quantifies morphological characteristics of 3D breast culture acini with varying metastatic potentials. J Biomed Biotechnol 2012: 16
56. Withana NP, Blum G et al (2012) Cathepsin B inhibition limits bone metastasis in breast cancer. Cancer Res 72(5): 1199-1209
57. Xiong G, Wang C et al (2012) RORalpha suppresses breast tumor invasion by inducing SEMA3F expression. Cancer Res 72(7): 1728-1739
58. Rothberg JM, Sameni M et al (2012) Live-cell imaging of tumor proteolysis: impact of cellular and non-cellular microenvironment. Biochim Biophys Acta 1824(1): 123-132
59. Sameni M, Anbalagan A et al (2012) MAME models for 4D live-cell imaging of tumor: microenvironment interactions that impact malignant progression. J Vis Exp (60)
60. Moin K, Sameni M et al (2012) 3D/4D functional imaging of tumor-associated proteolysis: impact of microenvironment. Methods Enzymol 506: 175-194
61. Miller FR, Soule HD et al (1993) Xenograft model of progressive human proliferative breast disease. J Natl Cancer Inst 85(21): 1725-1732
62. Strickland LB, Dawson PJ et al (2000) Progression of premalignant MCF10AT generates heterogeneous malignant variants with characteristic histologic types and immunohistochemical markers. Breast Cancer Res Tr 64(3): 235-240
63. Santner SJ, Dawson PJ et al (2001) Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells. Breast Cancer Res Tr 65(2): 101-110
64. Dawson PJ, Wolman SR et al (1996) MCF10AT: a model for the evolution of cancer from proliferative breast disease. Am J Pathol 148(1): 313-319
65. Miller FR (2000) Xenograft models of premalignant breast disease. J Mammary Gland Biol Neoplasia 5(4): 379-391
66. Tredan O, Galmarini CM et al (2007) Drug resistance and the solid tumor microenvironment. J Natl Cancer Inst 99(19): 1441-1454
67. Sharma SV, Haber DA et al (2010) Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents. Nat Rev Cancer 10(4): 241-253
68. Rak JW, Kerbel RS (1993) Growth advantage (clonal dominance) of metastatically competent tumor cell variants expressed under selective two-or three-dimensional tissue culture conditions. In Vitro Cell Dev Biol Anim 29A(9): 742-748
69. dit Faute MA, Laurent L et al (2002) Distinctive alterations of invasiveness, drug resistance and cell-cell organization in 3D-cultures of MCF-7, a human breast cancer cell line, and its multidrug resistant variant. Clin Exp Metastasis 19(2): 161-168
70. Horning JL, Sahoo SK et al (2008) 3-D tumor model for in vitro evaluation of anticancer drugs. Mol Pharm 5(5): 849-862
71. Weigelt B, Lo AT et al (2010) HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment. Breast Cancer Res Tr 122(1): 35-43
72. Yamada KM, Cukierman E (2007) Modeling tissue morphogenesis and cancer in 3D. Cell 130(4): 601-610
73. Friedrich J, Seidel C et al (2009) Spheroid-based drug screen: considerations and practical approach. Nat Protoc 4(3): 309-324
74. Correia AL, Bissell MJ (2012) The tumor microenvironment is a dominant force in multidrug resistance. Drug Resist Updat
75. Ghajar CM, Bissell MJ (2008) Extracellular matrix control of mammary gland morphogenesis and tumorigenesis: insights from imaging. Histochem Cell Biol 130(6): 1105-1118
76. Hutmacher DW, Loessner D et al (2010) Can tissue engineering concepts advance tumor biology research? Trends Biotechnol 28(3): 125-133
77. Blum G, Mullins SR et al (2005) Dynamic imaging of protease activity with fluorescently quenched activity-based probes. Nat Chem Biol 1(4): 203-209
78. Sameni M, Dosescu J et al (2008) Functional live-cell imaging demonstrates that beta1-integrin promotes type IV collagen degradation by breast and prostate cancer cells. Mol Imaging 7(5): 199-213
79. Cavallo-Medved D, Rudy D et al (2009) Live-cell imaging demonstrates extracellular matrix degradation in association with active cathepsin B in caveolae of endothelial cells during tube formation. Exp Cell Res 315(7): 1234-1246
80. Sameni M, Cavallo-Medved D et al (2009) Imaging and quantifying the dynamics of tumorassociated proteolysis. Clin Exp Metastasis 26(4): 299-309
81. Evans CL, Abu-Yousif AO et al (2011) Killing hypoxic cell populations in a 3D tumor model with EtNBS-PDT. PLoS ONE 6(8): e23434
82. Jedeszko C, Sameni M, Olive MB, Moin K, Sloane BF (2008) Visualizing protease activity in living cells: from two dimensions to four dimensions. Curr Protoc Cell Biol 39: 4. 20. 1-4. 20. 15